Current Neuropharmacology
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 9
Author(s): A.M. Barr
Affiliation:
Export Options
About this article
Cite this article as:
Barr A.M., Meet Our Editorial Board Member , Current Neuropharmacology 2019; 17 (9) . https://dx.doi.org/10.2174/1570159X1709190729101055
DOI https://dx.doi.org/10.2174/1570159X1709190729101055 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
19
2
1
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
AT1 Receptor Antagonists
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Metabolic Fate of Endocannabinoids
Current Neuropharmacology Pro-Drugs for Indirect Cannabinoids as Therapeutic Agents
Current Drug Delivery Immunotherapy for Targeting Tau Pathology in Alzheimer’s Disease and Tauopathies
Current Alzheimer Research Preface [Hot Topic: Cannabinoid Receptors (Guest Editor: Maria L. Lopez-Rodriguez)]
Current Medicinal Chemistry - Central Nervous System Agents Frequency of Pituitary Tumor Apoplexy During Treatment of Prolactinomas with Dopamine Agonists: A Systematic Review
CNS & Neurological Disorders - Drug Targets Neurological Aspects of Grief
CNS & Neurological Disorders - Drug Targets Alzheimer's Disease: A Review from the Pathophysiology to Diagnosis, New Perspectives for Pharmacological Treatment
Current Medicinal Chemistry Recent Advances in the Rational Drug Design Based on Multi-target Ligands
Current Medicinal Chemistry Structure-Specific Ligand Recognition of Multistranded DNA Structures
Current Topics in Medicinal Chemistry New Tracers and New Perspectives for Molecular Imaging in Lewy Body Diseases
Current Medicinal Chemistry Editorial [ HPA Axis Guest Editor: Brian Dyck ]
Current Topics in Medicinal Chemistry Targeting Opioid and Neurokinin-1 Receptors to Treat Alcoholism
Current Medicinal Chemistry Low-dose Sevoflurane Attenuates Cardiopulmonary Bypass (CPB)- induced Postoperative Cognitive Dysfunction (POCD) by Regulating Hippocampus Apoptosis via PI3K/AKT Pathway
Current Neurovascular Research Dual Inhibitors of the Blood Coagulation Enzymes
Current Medicinal Chemistry Development and Potential Utility of Dual and Triple NK Receptor Antagonists
Current Topics in Medicinal Chemistry Salivary Genomics, Transcriptomics and Proteomics: The Emerging Concept of the Oral Ecosystem and their Use in the Early Diagnosis of Cancer and other Diseases
Current Genomics Adhesion Molecules in CNS Disorders: Biomarker and Therapeutic Targets
CNS & Neurological Disorders - Drug Targets Cholesterol, Lipids, Amyloid Beta, and Alzheimers
Current Alzheimer Research Nose to Brain Delivery of Galantamine Loaded Nanoparticles: In-vivo Pharmacodynamic and Biochemical Study in Mice
Current Drug Delivery